Goldmoney has a 168 per cent upside, Mackie Research says

Despite the pullback in cryptocurrencies, Goldmoney Inc. (Goldmoney Inc. Stock Quote, Chart, News: TSX:XAU) should benefit from its existing and new revenue lines, says Nikhil Thadani of Mackie Research Capital.

On Monday, the analyst maintained his “Speculative Buy” recommendation and 12-month target price of $8.25.

Last week, secure investment and payment services company Goldmoney reported its financials for the quarter and year ended March 31, 2018, with revenue for the quarter of $171 million, $31 million of which came from its cryptocurrency services, representing a 36.6 per cent increase over the previous quarter.

Thadani says that the company has done well over the past year to take advantage of the new interest in cryptocurrencies. “Management has proven to be astute capital allocators by opportunistically benefiting from last year’s crypto run-up,” he says in a client update. “XAU generated cash gains from this segment versus many newly launched & pre-product crypto and blockchain related companies.”

“Management has successfully added numerous new revenue producing offerings in our over two years following XAU,” he says. “A strong balance sheet (~$50 million in cash and restricted cash ex. ~$20 million in GICs), with no debt provides ample fuel to sustain organic growth initiatives. A renewed focus on growing high value users, geographic expansion (China joint venture & additional branches) serve as important growth drivers.”

The analyst says that even with the pullback in the crypto-space, custodian services such as Goldmoney’s will continue to be a necessary part of crypto’s gaining institutional traction.

Thadani has revised his estimates for XAU, calling for revenue, EBITDA and Adj EPS for FY2019 of $683.40 million (was $633.05 million), negative $6.4 million (was negative $5.3 million) and negative $0.08 (was negative $0.06), respectively.

The analyst’s $8.25 target represents a projected return of 168 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: xau
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago